6:05 PM
 | 
Apr 23, 2013
 |  BC Extra  |  Financial News

Ironwood discloses first full quarter of Linzess sales

Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD) was off $1.12 to $16.77 on Tuesday after the company and partner Forest Laboratories Inc. (NYSE:FRX) reported $4.5 million in net sales in the first full quarter of...

Read the full 148 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >